NO20003344L - Topiske øyepreparater inneholdende immunosuppressive midler - Google Patents

Topiske øyepreparater inneholdende immunosuppressive midler

Info

Publication number
NO20003344L
NO20003344L NO20003344A NO20003344A NO20003344L NO 20003344 L NO20003344 L NO 20003344L NO 20003344 A NO20003344 A NO 20003344A NO 20003344 A NO20003344 A NO 20003344A NO 20003344 L NO20003344 L NO 20003344L
Authority
NO
Norway
Prior art keywords
weight
hydroxy
ethanediyl
oxy
poly
Prior art date
Application number
NO20003344A
Other languages
English (en)
Other versions
NO20003344D0 (no
Inventor
Milan Stuchlik
Alexandr Jegorov
Vladimir Matha
Josef Stuchlik
Original Assignee
Galena As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galena As filed Critical Galena As
Publication of NO20003344D0 publication Critical patent/NO20003344D0/no
Publication of NO20003344L publication Critical patent/NO20003344L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det beskrives terapeutiske preparater for topisk oftalmisk påføring, inne- holdende fra 0,02 til 5,0 vekt% immunsuppressive midler tilhørende gruppen av monocykliske undekapeptider, makrolid-laktoner eller kortikosteroider, i en bærer omfattende opp til 10 vekt% polyalkylenglykol-polyuretan-kopolymerer. Nevnte kopolymerer består fortrinnsvis av poly(oksy-1,2-etandiyl)-a-hydro-o>- hydroksypolymerer med 1,1'-metylen-bis-(4-isocyanatcykloheksan) som har en gjennomsnittlig molekylvekt på fra 1000 til 3000 i en hydrofil bærer og fortrinnsvis av poly[oksy-(metyl-1,2-etandiyl)]-a-hydro-co-hydroksypolymerer med 1,1 '-metylen-bis- (4-isocyanatcykloheksan) som har en gjennomsnittlig molekylvekt på'fra 1600 til ¿ 18000 i en lipofil bærer. Nevnte terapeutiske midler kan dessuten inneholde hjelpestoffer som er vanlige i topiske administrasjonsformer.
NO20003344A 1997-12-30 2000-06-27 Topiske øyepreparater inneholdende immunosuppressive midler NO20003344L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ19974237A CZ287497B6 (cs) 1997-12-30 1997-12-30 Topické oční přípravky s imunosupresivními látkami
PCT/CZ1998/000054 WO1999034830A1 (en) 1997-12-30 1998-12-17 Topical ophthalmic preparations containing immunosuppressive agents

Publications (2)

Publication Number Publication Date
NO20003344D0 NO20003344D0 (no) 2000-06-27
NO20003344L true NO20003344L (no) 2000-06-27

Family

ID=5467853

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003344A NO20003344L (no) 1997-12-30 2000-06-27 Topiske øyepreparater inneholdende immunosuppressive midler

Country Status (12)

Country Link
EP (1) EP1058560A1 (no)
JP (1) JP2002500200A (no)
AU (1) AU1481399A (no)
BG (1) BG104558A (no)
CA (1) CA2317010A1 (no)
CZ (1) CZ287497B6 (no)
HR (1) HRP20000258A2 (no)
HU (1) HUP0004173A2 (no)
NO (1) NO20003344L (no)
PL (1) PL341604A1 (no)
SK (1) SK284246B6 (no)
WO (1) WO1999034830A1 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000038703A1 (en) * 1998-12-24 2000-07-06 R-Tech Ueno, Ltd. Agent for treating visual cell function disorder
US6864232B1 (en) 1998-12-24 2005-03-08 Sucampo Ag Agent for treating visual cell function disorder
TWI324925B (en) * 2001-08-23 2010-05-21 Novartis Ag Ophthalmic composition
SI1539157T1 (sl) * 2002-09-18 2013-11-29 Trustees Of The University Of Pennsylvania Rapamicin za uporabo pri inhibiciji ali preprečevanju horoidalne neovaskularizacije
US7354574B2 (en) 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
US7083802B2 (en) * 2003-07-31 2006-08-01 Advanced Ocular Systems Limited Treatment of ocular disease
JP2007505932A (ja) 2003-09-18 2007-03-15 マクサイト， インコーポレイテッド 経強膜送達
US7083803B2 (en) 2003-09-19 2006-08-01 Advanced Ocular Systems Limited Ocular solutions
US7087237B2 (en) 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
CA2597590A1 (en) 2005-02-09 2006-08-17 Macusight, Inc. Formulations for ocular treatment
WO2007011880A2 (en) 2005-07-18 2007-01-25 Minu, L.L.C. Enhanced ocular neuroprotection/neurostimulation
KR101478164B1 (ko) 2006-02-09 2014-12-31 산텐 세이야꾸 가부시키가이샤 안정한 제제와 그 제조 및 사용 방법
AU2007230964B2 (en) 2006-03-23 2012-07-19 Santen Pharmaceutical Co., Ltd. Formulations and methods for vascular permeability-related diseases or conditions
US10172789B2 (en) 2013-01-24 2019-01-08 Palvella Therapeutics Llc Compositions for transdermal delivery of mTOR inhibitors
HK1216146A1 (zh) * 2013-03-27 2016-10-21 Comprehensive Drug Enterprises, Ltd. 眼药组合物、其制备方法及用途
US11622929B2 (en) 2016-03-08 2023-04-11 Living Proof, Inc. Long lasting cosmetic compositions
WO2018129364A1 (en) 2017-01-06 2018-07-12 Palvella Therapeutics Llc Anhydrous compositions of mtor inhibitors and methods of use
US10987300B2 (en) 2017-09-13 2021-04-27 Living Proof, Inc. Long lasting cosmetic compositions
US10842729B2 (en) 2017-09-13 2020-11-24 Living Proof, Inc. Color protectant compositions
AU2018370210B2 (en) 2017-11-20 2024-09-26 Living Proof, Inc. Properties for achieving long-lasting cosmetic performance
BR112020021902B1 (pt) 2018-04-27 2024-02-20 Living Proof, Inc Composições cosméticas de poliuretano-ureia para tratamento capilar, método de preservação da ondulação no cabelo humano e os usos de poliuretano-ureia
EP3817743A4 (en) 2018-07-02 2022-07-06 Palvella Therapeutics, Inc. ANHYDROUS COMPOSITIONS OF MTOR INHIBITORS AND METHODS OF USE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5045317A (en) * 1987-07-16 1991-09-03 The Regents Of The University Of California Enhancing the cutaneous penetration of pharmacologically active agents
US4971800A (en) * 1988-07-08 1990-11-20 The Regents Of The University Of California Method and compositions for enhancing the cutaneous penetration of pharmacologically active agents
US5051260A (en) * 1987-07-16 1991-09-24 The Regents Of The University Of California Method and composition for enhancing the cutaneous penetration of pharmacologically active agents

Also Published As

Publication number Publication date
NO20003344D0 (no) 2000-06-27
HRP20000258A2 (en) 2001-04-30
BG104558A (en) 2001-02-28
JP2002500200A (ja) 2002-01-08
WO1999034830A1 (en) 1999-07-15
AU1481399A (en) 1999-07-26
EP1058560A1 (en) 2000-12-13
SK284246B6 (sk) 2004-12-01
SK171798A3 (en) 1999-10-08
CZ423797A3 (cs) 1999-07-14
PL341604A1 (en) 2001-04-23
CZ287497B6 (cs) 2000-12-13
CA2317010A1 (en) 1999-07-15
HUP0004173A2 (hu) 2001-08-28

Similar Documents

Publication Publication Date Title
BG104558A (en) Topical ophthalmic preparations containing immunosuppressive agents
CA2231886A1 (en) Copolymeric micelle drug composition and method for the preparation thereof
DE59109137D1 (de) Wässrige Polyurethanzubereitungen
HK1054684A1 (zh) 包含高分子量聚环氧乙烷的多价平台分子
DK1531800T3 (da) Stealth-lipidnanokapsler, fremgangsmåder til fremstilling deraf som en bærer for aktivt princip(per)
CA2355705A1 (fr) Polyetheresteramides et compositions de polymeres antistatiques les contenant
CA2271139A1 (en) Percutaneous delivery system
WO2003068144A3 (en) Cytotoxic agents
CA2063521A1 (en) Tacky, hydrophilic gel dressings and products therefrom
WO2000040203A3 (en) Polymeric delivery agents and delivery agent compounds
EP1371675A4 (en) COPOLYCARBONATE DIOL AND THERMOPLASTIC POLYURETHANE OBTAINED FROM IT
NO912243D0 (no) Forbedrede polymer/polyol-blandinger som egner seg for anvendelse ved fremstilling av polyuretaner, og forhaandsformede stabilisatorsystemer for anvendelse ved fremstilling av polymer/polyol-blandingene.
WO1995017165A3 (en) Tissue moisturizing and antimicrobial compositions
EP1754472A3 (en) Compositions for treatment of disorders associated with chlamydia
CA2336149A1 (en) A membrane or matrix for controlling the permeation rate of drugs
EP0913416A4 (en) BIOCOMPATIBLE POLYMERS
WO2024192323A3 (en) Ophthalmic cream formulations and their uses
EP1048297A3 (en) Use of polyethylene glycol for reducing of intestinal gas, cramping and anorectal irritation
FI955524A0 (fi) Kiinteinä liuoksina olevia valmisteita
WO2001046935A3 (en) Method for helping persons with dyslexia
CA2394200A1 (en) Novel forms of pravastatin sodium
EP0354714A3 (en) Pharmaceutical compositions containing polyaromatic compounds
EP0380989A3 (en) Plaster for transdermal administration
EP1127575A3 (en) Ocular tissue regeneration inducer
CO4230094A1 (es) Composiciones

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application